Estudo randomizado | Sobrevida geral do câncer de mama avançado com ribociclibe e letrozol.

Overall Survival with Ribociclib plus Letrozole in Advanced Breast Cancer – New England Journal of Medicine (link para o resumo – $ para o texto completo)

Comentários:

Ribociclib plus endocrine therapy offers survival benefit for postmenopausal patients with metastatic breast cancer – University of Texas MD Anderson Cancer Center / News Medical

Adding Ribociclib to Letrozole Prolongs Survival in Advanced Breast Cancer – HealthDay